Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticosteroids in Interstitial Lung Diseases
NCT04982809Completed
- Sponsor
- Cairo University
- Start
- Jul 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial in hypersensitivity pneumonitis (HP) and interstitial lung disease (ILD) comparing Betamethasone group, Dexamethasone group and Prednisolone group (3 arms). Primary endpoint: Krebs von den Lungen - 6 at 3 months. Started Jul 2018; status: completed.
02
Drugs
betamethasonedexamethasoneprednisolone
03
Conditions
hypersensitivity pneumonitis (HP)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT04982809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04982809.